NLS Pharmaceutics AG
NLSP
$1.47
-$0.053-3.48%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.53% | -66.53% | -89.97% | -89.97% | 21.95% |
| Total Receivables | 25.97% | 25.97% | -14.81% | -14.81% | 7.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -39.52% | -39.52% | -63.87% | -63.87% | -16.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 591.53% | 591.53% | 1,150.08% | 1,150.08% | 62.93% |
| Total Current Assets | -46.89% | -46.89% | -80.28% | -80.28% | 11.01% |
|
|
|||||
| Total Current Assets | -46.89% | -46.89% | -80.28% | -80.28% | 11.01% |
| Net Property, Plant & Equipment | -91.94% | -91.94% | -62.98% | -62.98% | -47.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 39.67% | 39.67% | 7.69% |
| Total Assets | -47.43% | -47.43% | -80.09% | -80.09% | 10.31% |
|
|
|||||
| Total Accounts Payable | 47.26% | 47.26% | 95.23% | 95.23% | 23.44% |
| Total Accrued Expenses | 82.24% | 82.24% | 58.17% | 58.17% | 62.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 766.15% | 766.15% | -- |
| Total Other Current Liabilities | -- | -- | 766.15% | 766.15% | -- |
| Total Current Liabilities | 98.29% | 98.29% | 135.72% | 135.72% | 14.12% |
|
|
|||||
| Total Current Liabilities | 98.29% | 98.29% | 135.72% | 135.72% | 14.12% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.96% | 2.96% | 4.73% | 4.73% | -0.90% |
| Total Liabilities | 59.55% | 59.55% | 78.13% | 78.13% | 7.50% |
|
|
|||||
| Common Stock & APIC | 2.40% | 2.40% | 0.37% | 0.37% | 32.96% |
| Retained Earnings | -10.02% | -10.02% | -20.91% | -20.91% | -30.72% |
| Treasury Stock & Other | 103.20% | 103.20% | -338.78% | -338.78% | -91.95% |
| Total Common Equity | -116.21% | -116.21% | -369.25% | -369.25% | -6.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -116.21% | -116.21% | -369.25% | -369.25% | -6.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -116.21% | -116.21% | -369.25% | -369.25% | -6.07% |
|
|
|||||